Follow-up after treatment for ovarian cancer

Last medical review:

Follow-up care lets your healthcare team keep track of your health for a period of time after treatment ends. This important part of cancer care is often shared among the cancer specialists and your family doctor. They will help you recover from treatment side effects and monitor you for any signs that the cancer has come back (recurred).  

Follow-up care may not seem that important to you, especially if your treatment was long or very hard. You may find the idea of follow-up care stressful because it reminds you of your cancer experience or because you are worried about what a test might reveal. Talk to your healthcare team about how you feel and about why follow-up matters. Your healthcare team is there to help. 

Schedule for follow-up visits

Don't wait until your next scheduled appointment to report any new symptoms, and symptoms that don't go away. Tell your healthcare team if you have:

  • pain in the legs, lower back, pelvis or abdomen
  • swelling of or pain in the abdomen
  • change in bowel habits
  • increasing bloating, nausea or vomiting
  • weight loss

The chance that ovarian cancer will come back (recur) is greatest within 5 years, so you will need close follow-up during this time. You will also need close follow-up care for fallopian tube or primary peritoneal cancer, which are very similar to ovarian cancer. These cancers start in the same tissue as most ovarian cancers and are staged and treated the same way. But they are much rarer cancers.

Follow-up visits for ovarian, fallopian tube and primary peritoneal cancer are usually scheduled:

  • every 3 to 4 months for the first 2 to 3 years after finishing initial treatment
  • every 4 to 6 months for the next 3 years, and then once a year after that

During follow-up visits

During a follow-up visit, your healthcare team will usually ask questions about the side effects of treatment and how you’re coping.

Your doctor may do a physical exam, including:

  • a pelvic exam
  • feeling the neck, abdomen and legs for swelling
  • feeling the lymph nodes in the groin

Tests are often part of follow-up care. You may have:

Tumour marker tests

Tumour marker tests may be done to monitor how the treatment is working. Rising levels of a tumour marker may mean that the cancer has recurred. The doctor may order tests for different tumour markers for different types of cancer:

  • cancer antigen 125 (CA125)
  • alpha-fetoprotein (AFP)
  • human chorionic gonadotropin (HCG or b-HCG)
  • carcinoembryonic antigen (CEA)

Blood chemistry tests

Blood chemistry tests may be done to show how well certain organs are working. They can also be used to find abnormalities that may mean the cancer has spread to certain organs.

A complete blood count (CBC) may be done to check for anemia from long-term bleeding, especially if the cancer has spread to the small or large intestine (also called the bowel).

Imaging tests

Imaging tests may be ordered to check how the treatment is working or to investigate new symptoms:

If the cancer has come back, you and your healthcare team will discuss a plan for your treatment and care.

Find out more about follow-up

The following are questions that you can ask the healthcare team about follow-up after treatment for cancer. Choose the questions that fit your situation and add questions of your own. You may find it helpful to take the list to the next appointment and to write down the answers.

  • What is the schedule for follow-up visits?
  • How often is follow-up scheduled with the cancer specialist?
  • Who is responsible for follow-up visits?
  • What will happen at a follow-up visit?
  • What tests are done on a regular basis? How often are they done?
  • Are there any symptoms that should be reported right away? Who do I call?
  • Who can help me cope with long-term side effects of treatment?

Expert review and references

  • Laurie Elit, MD, MSc, FRCSC
  • American Cancer Society. Ovarian Cancer. 2018. https://www.cancer.org/.
  • Provincial Health Services Authority. Ovary - Epithelial Carcinoma. Vancouver, BC: 2024. https://www.bccancer.bc.ca/.
  • Filippova O.T, Stasenko M. Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®) – Health Professional Version. Bethesda, MD: National Cancer Institute; https://www.cancer.gov/.
  • Martin VR, Stewart L. Ovarian Cancer. Yarbro CH, Wujcik D, Gobel B (eds.). Cancer Nursing: Principles and Practice. 8th ed. Burlington, MA: Jone & Bartlett Learning; 2018: Kindle version, [chapter 63].

Your trusted source for accurate cancer information

With just $5 from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

If everyone reading this gave just $5, we could achieve our goal this month to fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society